medigraphic.com
SPANISH

Revista Mexicana de Mastología

ISSN 1870-2821 (Print)
Organo Oficial de la Asociación Mexicana de Mastología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2020, Number 1

<< Back Next >>

Rev Mex Mastol 2020; 10 (1)

Clinical-histopathologic correlation of the findings radiologics of category BI-RADS 4a, 4b and 4c breast lesions

López ZJ, Vázquez MCG
Full text How to cite this article 10.35366/95762

DOI

DOI: 10.35366/95762
URL: https://dx.doi.org/10.35366/95762

Language: Spanish
References: 5
Page: 13-17
PDF size: 214.39 Kb.


Key words:

Mammography, BI-RADS, microcalcifications, premalignant lesions, in situ carcinoma, invasive carcinoma.

ABSTRACT

Breast cancer is the most common malignant neoplasm in women worldwide. In Mexico each year 11 thousand new cases of breast cancer are diagnosed, which represents an increase of almost 20% in the last three years, which is why it is considered a public health problem. Mammography is the only diagnostic method accepted as a screening technique for breast cancer, allowing its early detection and the only one that has shown a reduction in mortality rates from breast cancer. The BI-RADS system subdivides lesions suspected of malignancy into three subgroups: 4a (low suspicion of malignancy, 2-10%), 4b (intermediate suspicion, 11-50%) and 4c (high suspicion, 51-94%). The objective of this study is to present the clinical-histopathological correlation of the radiological findings of the mastological studies classified as BI-RADS 4a, 4b and 4c of 171 patients who were studied at the Hospital General de Zona No. 16 of the Instituto Mexicano del Seguro Social in Torreón, Coahuila, who underwent breast biopsy due to mastic suspicion of breast cancer in the period from January to December 2019. We conclude that mammography is the only diagnostic method accepted as a screening technique for breast cancer allowing its detection early and the only one that has shown a reduction in mortality rates. It is important to correlate the characteristic radiological findings of benign and malignant lesions in BI-RADS categories 4a, 4b and 4c with the histopathological results to define the treatment for each case based on their diagnosis.


REFERENCES

  1. NOM-041-SSA2-2011 Para la prevención, diagnóstico, tratamiento, control y vigilancia epidemiológica del cáncer de mama. Junio 09, 2011. pp. 61-101.

  2. Nelson HD, Tyne K, Naik A et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2017; 151 (10): 727-737.

  3. Febles G, Parada J, Folle E. Localización de las lesiones mamarias subclínicas con marcador metálico (arponaje): análisis de los márgenes quirúrgicos. Rev Med Urug. 2016; 26: 84-91.

  4. Soo MS, Baker JA, Rosen EL. Sonographic detection and sonographically guided biopsy of breast microcalcifications. AJR Am J Roentgenol. 2003; 180 (4): 941-948.

  5. Marini C, Traino C, Cilotti A, Roncella M, Campori G, Bartolozzi C. Differentiation of benign and malignant breast microcalcifications: mammography versus mammography-sonography combination. Radiol Med (Torino). 2003; 105 (1-2): 17-26.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Mastol. 2020;10